Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


IntraLase Eye Lasers Continue To Take Share From Microkeratome Blades

This article was originally published in The Gray Sheet

Executive Summary

IntraLase estimates that its FS precision laser will be used in 25% of U.S. corneal flap procedures by next year, up from 16% in the fourth quarter of 2004

You may also be interested in...

AMO To Surround Eye Surgeons With Refractive Offerings After Visx Purchase

Advanced Medical Optics' acquisition of pure-play LASIK manufacturer Visx will enable the combined entity to more effectively market laser eye surgery to physicians performing both refractive and cataract procedures

Eye Laser Company IPO Contends With Microkeratome Competition, Debt

IntraLase Corp. will target its IntraLase FS precision laser to the 1,400 LASIK centers in the U.S. and 4,100 abroad that perform at least 50 procedures per month, the firm says in its IPO prospectus, filed with the Securities & Exchange Commission May 28

Hanmi And LG Chem Highlight Vaccine Prowess, Novel R&D At JPM

Hanmi showcases at JPM its contract production capabilities for COVID-19 vaccines as South Korea prepares to bring in candidates from several global developers, while LG Chem highlights progress across multiple pipeline projects.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts